FDA Recalls 250,000+ Catheters

Patient safety was compromised as the catheters were prone to separation and leakage.

Teleflex
Teleflex

Catheters have a pretty specific function, and that definitely does not include separating or leaking. According to a recent Cardiovascular Business article, the FDA issued a Class I recall for over 250,000 catheters manufactured by Arrow International, a subsidiary of Teleflex. As you’ve probably guessed, the recall is due to the risk of device separation and leakage, which can lead to serious injuries or death. The affected product is the Arrow Endurance Extended Dwell Peripheral Catheter System, commonly used for short-term access to a patient's peripheral vascular system during procedures like blood sample collection or fluid administration. 

List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
List: Digitalization Companies From PACK EXPO
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?